Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Sep 15, 2021

Accession no.
0001209191-21-056095
Filed
Sep 15, 2021, 7:09 AM ET
Trade date
Sep 14, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions. Open-market purchases total $346.4K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 14, 2021Common StockPPurchaseAcquired+500$3.45+$1,722.5193,072,194Indirect
Sep 14, 2021Common StockPPurchaseAcquired+5,825$3.45+$20,090.43193,078,019Indirect
Sep 14, 2021Common StockPPurchaseAcquired+21,905$3.45+$75,572.25193,099,924Indirect
Sep 14, 2021Common StockPPurchaseAcquired+10,100$3.46+$34,895.5193,110,024Indirect
Sep 14, 2021Common StockPPurchaseAcquired+400$3.47+$1,386193,110,424Indirect
Sep 14, 2021Common StockPPurchaseAcquired+44,085$3.47+$152,974.95193,154,509Indirect
Sep 14, 2021Common StockPPurchaseAcquired+400$3.48+$1,390193,154,909Indirect
Sep 14, 2021Common StockPPurchaseAcquired+16,785$3.48+$58,411.8193,171,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)